Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is T  [Clear All Filters]
2024
Li Z, Xu Z-M, Chen W-P, Du X-J, Ou C-X, Luo Z-K, Wang R, Zhang C-Q, Ge C-D, Han M, et al. Tumor-repopulating cells evade ferroptosis via PCK2-dependent phospholipid remodeling. Nat Chem Biol. 2024.
Hu C, Qiao W, Li X, Ning Z-K, Liu J, Dalangood S, Li H, Yu X, Zong Z, Wen Z, et al. Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8T cells. Cell Metab. 2024.
Zhang D-F, Jin X-N, Ma X, Qiu Y-S, Ma W, Dai X, Zhang Z. Tumour necrosis factor α regulates the miR-27a-3p-Sfrp1 axis in a mouse model of osteoporosis. Exp Physiol. 2024.
Lee HKeun, Kim SYoung, Chung S-H, Choi B, Kim J-eun, Yoon D, Jang SIll, Yeo A, Kang HGoo, Lee J, et al. Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pancreatic ductal adenocarcinoma. Br J Cancer. 2024.
Martinier I, Fage F, Kakar A, Castagnino A, Saindoy E, Frederick J, Onorati I, Besnard V, Barakat AI, Dard N, et al. Tunable biomimetic materials elaborated by ice templating and self-assembly of collagen for tubular tissue engineering. Biomater Sci. 2024.
Newton JD, Song Y, Park S, Kanagarajah KR, Wong AP, Young EWK. Tunable In Situ Synthesis of Ultra-Thin Extracellular Matrix-Derived Membranes in Organ-on-a-Chip Devices. Adv Healthc Mater. 2024:e2401158.
Torcq L, Majello S, Vivier C, Schmidt AA. Tuning apicobasal polarity and junctional recycling in the hemogenic endothelium orchestrates the morphodynamic complexity of emerging pre-hematopoietic stem cells. Elife. 2024;12.
Simons BD, Karin O. Tuning of plasma cell lifespan by competition explains the longevity and heterogeneity of antibody persistence. Immunity. 2024.
Özkan SGülkan, Kimiaei A, Kaya AHakan, Pepeler MSezgin, Ozkan HAtilla, Arat M. Turkish Hematologists' Preferences for Relative Donor Selection: Results of a Multicenter Survey. Turk J Haematol. 2024.
Wyse RK, Isaacs T, Barker RA, Cookson MR, Dawson TM, Devos D, Dexter DT, Duffen J, Federoff H, Fiske B, et al. Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials initiative. J Parkinsons Dis. 2024.
Regeenes R, Rocheleau JV. Twenty years of islet-on-a-chip: microfluidic tools for dissecting islet metabolism and function. Lab Chip. 2024.
Major-Monfried H, Hosszu K, McAvoy DP, Vallone A, Shukla N, Gillio A, Spitzer B, Kung AL, Cancio M, Curran K, et al. Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation. Cytotherapy. 2024.
Khoddam S, Kamal N, Shiri A, Khamirani HJafari, Manoochehri J, Dianatpour M, Tabei SMohammad B, Dastgheib SAlireza. Two siblings with PEX11B-related peroxisome biogenesis disorder. Eur J Med Genet. 2024:104928.
Hosea R, Hillary S, Naqvi S, Wu S, Kasim V. The two sides of chromosomal instability: drivers and brakes in cancer. Signal Transduct Target Ther. 2024;9(1):75.
Ma S, Ge L, Lu H, Yan J, Yang K. Two undescribed compounds from , an endophytic fungus isolated from . Nat Prod Res. 2024:1-8.
Villaseñor S, Grinstein M. Two-Photon Microscopy for the Study of Tendons. J Vis Exp. 2024;(205).
Guo J-J, Wang C-R, Liu Z-Q, Huang Q-Q, Zhang C-B, Huang Y-C, Xue W-J, Sun Y-B. [Two-stage Inhibition Effects of sp. Y4 Application on Cadmium Uptake and Transport in Wheat]. Huan Jing Ke Xue. 2024;45(2):1150-1160.
Kelly K, Bloor AJC, Griffin JE, Radia R, Yeung DT, Rasko JEJ. Two-year safety outcomes of iPS cell-derived mesenchymal stromal cells in acute steroid-resistant graft-versus-host disease. Nat Med. 2024.
Marin C, Alobid I, López-Chacón M, VanStrahlen CR, Mullol J. Type 2 and Non-type 2 Inflammation in the Upper Airways: Cellular and Molecular Alterations in Olfactory Neuroepithelium Cell Populations. Curr Allergy Asthma Rep. 2024.
Moe A, Rayasam A, Sauber G, Shah RK, Doherty A, Yuan C-Y, Szabo A, Ii BMMoore, Colonna M, Cui W, et al. Type 2 cannabinoid receptor expression on microglial cells regulates neuroinflammation during graft versus host disease. J Clin Invest. 2024.
Escoubas CC, Dorman LC, Nguyen PT, Lagares-Linares C, Nakajo H, Anderson SR, Barron JJ, Wade SD, Cuevas B, Vainchtein ID, et al. Type-I-interferon-responsive microglia shape cortical development and behavior. Cell. 2024.
Réa D, Fodil S, Lengline E, Raffoux E, Cayuela J-M. Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Strategies to Optimize Success and New Directions. Curr Hematol Malig Rep. 2024.
2023
Adu-Berchie K, Obuseh FO, Mooney DJ. T cell development and function. Rejuvenation Res. 2023.
Hirschhorn D, Budhu S, Kraehenbuehl L, Gigoux M, Schröder D, Chow A, Ricca JM, Gasmi B, De Henau O, Mangarin LMark B, et al. T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants. Cell. 2023;186(7):1432-1447.e17.
Katsuyama N, Kawase T, Barakat C, Mizuno S, Tomita A, Ozeki K, Nishio N, Sato Y, Kajiya R, Shiraishi K, et al. T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation. Nagoya J Med Sci. 2023;85(4):779-796.

Pages